HomeHealth articlessanfilippo syndromeWhat Is Sanfilippo Syndrome?

Sanfilippo Syndrome - Causes, Symptoms, and Treatment

Verified dataVerified data
0

4 min read

Share

Sanfilippo syndrome is a rare genetic autosomal recessive lysosomal storage disease affecting the brain and spinal cord. To know more, read the article below.

Medically reviewed by

Dr. Kaushal Bhavsar

Published At August 24, 2022
Reviewed AtAugust 24, 2022

What Is Sanfilippo Syndrome?

Sanfilippo syndrome is a progressive neurodegenerative disease that primarily affects the brain and the spinal cord. This condition is predominantly genetic and is considered an autosomal recessive disorder. Though this syndrome initially affects the central nervous system, it leads to deterioration in the brain's normal functioning over time. The decreasing brain function causes various health issues associated with other body parts, such as limbs and facial muscle coordination.

People with Sanfilippo syndrome do not show any clinical features at birth, and the signs and symptoms usually develop during early childhood. Sanfilippo syndrome is also known by the name mucopolysaccharidosis type III or MPS III. There are four subtypes of Sanfilippo syndrome, which are denoted by the letters A, B, C, and D.

Among the four types of Sanfilippo syndrome, type A is the most severe and common type. Type B Sanfilippo syndrome then follows this as the second common subtype. Type C and D are scarce and only account for roughly one case in one million cases of Sanfilippo syndrome. Statistically speaking, Sanfilippo syndrome is a rare condition that affects only one in 70,000 children. It has been commonly reported that the symptoms appear only after three years of age.

What Are the Causes of Sanfilippo Syndrome?

There are four subtypes of Sanfilippo syndrome, and they are caused due to either of the following reasons.

  • Genetic mutation.

  • Genetic defect.

  • Genetic variation.

This condition is caused when the body does not break down a complex sugar molecule called heparan sulfate, which is a part of the glycosaminoglycans (GAG). Our body usually produces heparan sulfate, and then it is broken down with the help of the metabolic processes to help in regulating regular body functioning, such as:

  • Repair of the wound.

  • Cell growth.

  • Cartilage repair and growth.

  • Cell signaling.

  • Clotting of blood.

  • Connective tissue growth.

  • Building of nerve tissues.

Hence if our body is not breaking down heparan sulfate in sufficient quantity, the level of heparan sulfate gets accumulated, which leads to the following.

  • Organ damage.

  • Delay in neurological development.

  • Changes in behaviors.

  • Problems in growth.

  • Neurological deterioration.

The four subtypes of Sanfilippo syndrome are caused due to a deficiency or a mutation of four different types of enzymes responsible for breaking down heparan sulfate. The genes that are responsible for each subtype of Sanfilippo syndrome or MPS are:

  • SGSH gene, in MPS III-A.

  • NAGLU gene, in MPS III-B.

  • HGSNAT gene, in MPS III-C.

  • GNS gene, in MPS III-D.

What Are the Symptoms of Sanfilippo Syndrome?

Although Sanfilippo syndrome is a genetic condition (meaning, children are born with this condition), symptoms usually begin to exhibit only when the child is at least two years old. Some of the typical early signs of Sanfilippo syndrome include:

  • Hyperactivity or compulsive disorders.

  • Trouble sleeping.

  • Developmental delays.

  • Stiff joints.

  • Trouble or difficulty in speaking.

  • Coordination issues result in mobility issues.

  • Heavy elbows or abnormal head size.

These are some of the early symptoms, and the symptoms become worse as the child gets older. The severity of the symptoms differs from one person to another based on the rate of progression of the disease. Health care professionals have classified three stages of developmental issues based on research involving individuals affected by Sanfilippo syndrome.

They are,

  • Stage 1: During the age of 1 to 3, the child will have delayed cognitive development. Also, there will be frequent infections of the eyes, nose, throat, or ears.

  • Stage 2: When the child is between the ages of 3 to 5, behavioral changes such as difficulty sleeping and a decline in cognitive development occur. Stage 2 continues until the child is 13 to 15 years of age.

  • Stage 3: The final stage includes regression of fundamental motor skills and cognitive functions. During this stage, the child might start losing language skills and continue to have other physical issues such as breathing troubles or seizures.

How Is Sanfilippo Syndrome Diagnosed?

It is highly crucial to diagnose Sanfilippo syndrome early during childhood to provide the child with the necessary support. The doctor first performs a physical examination, and if he suspects Sanfilippo syndrome, the following tests would be recommended by the doctor to effectively help diagnose the disease. They are:

  • Blood test.

  • Urine test.

  • Genetic test.

  • Supplemental newborn screening.

The first step involves the urine MPS test, specifically designed to identify GAGs and heparan sulfate levels. If this test produces a positive result (increased level of heparin sulfate), then a blood enzyme test is done to reconfirm the result. The blood test will have a more accurate finding of which enzyme cannot break down the heparan sulfate and hence helps find the type of Sanfilippo syndrome.

The genetic test includes providing blood or saliva samples to screen for any genetic mutations or variations associated with Sanfilippo syndrome. Another non-official way of detecting Sanfilippo syndrome is a supplemental screening of a baby under the age of one.

How Is Sanfilippo Syndrome Treated?

At present, there is no apparent cure for Sanfilippo syndrome. However, there have been many clinical and research trials involving stem cell research and animal trials for treating Sanfilippo syndrome. These trials include:

  • Gene therapy.

  • Enzyme replacement therapy (ERT).

  • Substrate reduction therapy (SRT).

Gene therapy and ERT have been more promising in managing the condition of these three. Even if these options do not cure the disease permanently, they are an efficient way to help manage most of the symptoms and improve the quality of the individual affected by Sanfilippo syndrome. They help stabilize the situation, but more research and human trials are still required to make this a viable treatment option.

Conclusion:

Sanfilippo syndrome is a severe health condition, and it reduces the life expectancy of the affected person by up to 10 to 20 years. Many research and clinical trials are conducted by the government and pharma companies in the hope of finding a cure. However, in the meantime, there are still options for managing some of the severe symptoms and improving the quality of life of the affected person, but it is essential to get early treatment. Hence it is vital to reach out to your doctor as early as possible if you notice any of the mentioned symptoms in your child.

Source Article IclonSourcesSource Article Arrow
Dr. Kaushal Bhavsar
Dr. Kaushal Bhavsar

Pulmonology (Asthma Doctors)

Tags:

sanfilippo syndrome
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

sanfilippo syndrome

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy